SINTX Technologies opened lower at $1.60, compared with its previous close of $1.62. In the last trading session, the stock traded between $1.53 and $1.61. It showed a downward intraday trend.
An investment of $100 made 5 years ago in SINTX Technologies is now worth
$ 0.01
Resulting in a loss of
$ 99.99 (99.99%)
Note: Past profits do not guarantee future returns.
Rating from 3 Analysts
Today's Change
$-0.08 (-5.12%)
Day High
$1.61
Day Low
$1.53
Day Open
$1.60
Prev Close
$1.62
Volume
19,135
1W Return
-7.41%
1M Return
-27.47%
3M Return
-13.41%
6M Return
-38.02%
1Y Return
-58.12%
Market Cap ($ Mn)
12
PE Ratio
-
PB Ratio
2.05
PEG Ratio
-
ROE
-247.10%
ROCE
-143.67%
EPS (TTM)
$-0.55
1 Week
-7.41%
1 Month
-27.47%
3 Months
-13.41%
6 Months
-38.02%
9 Months
-47.36%
Sintx Technologies Q3FY26 Results: Revenue jumps 953% to $2.2 million
Revenue surged 953% YoY to $2.2 million, driven by aerospace ceramics. Net loss narrowed 55% YoY to $1.6 million; gross margins expanded to 62%. Warrant call execution yielded $2 million in capital proceeds. Cash balance declined to $2 million; inventory rose to $2.6 million.
7 days agoSINTX Technologies launches silicon nitride orthopedics masterclass with OTW
SINTX Technologies partners with Orthopedics This Week for a silicon nitride masterclass. Experts compare silicon nitride properties against legacy materials like PEEK and titanium. Company highlights SiNERGY biocomposite platform for antibacterial textile applications. Target audience includes over 400,000 annual readers across 120 countries.
1mo agoSINTX Technologies to present at H.C. Wainwright Global Investment Conference
SINTX Technologies to present at H.C. Wainwright conference Sept 14-16, 2026. Executives to highlight FDA-cleared SINAPTIC Foot & Ankle Implant System. Focus includes silicon nitride tech adoption and contract manufacturing growth. One-on-one investor meetings available via H.C. Wainwright or IR@sintx.com.
2mo agoSINTX Technologies Q2 Results: Revenue guidance set at $900K-$1.1M for Q3
SINTX Technologies Inc. highlighted commercial momentum with $3.2 million in new industrial orders and established revenue guidance of $900K-$1.1M for Q3 2026. The company raised $5.0 million in gross proceeds and expanded its orthopedic distributor network to support the SiNAPTIC implant system. Management emphasized cost optimization and strategic partnerships to drive long-term value from its silicon nitride platform.
3mo agoSINTX Technologies Q2 Results: Sales Surge 199% YoY, EPS Misses
SINTX Technologies delivered strong top-line growth in Q2, with sales rising 199.34% YoY to $452.000 thousand, beating estimates. However, EPS of $(0.75) missed the $(0.66) consensus, reflecting a 17.58% increase in losses compared to the prior year period.
3mo agoSINTX Technologies secures $3.2 million in contract manufacturing orders
SINTX Technologies, Inc. announced purchase orders exceeding $3.2 million for advanced ceramic components from existing contract manufacturing customers. Production is scheduled for the second half of 2026 through 2027, leveraging the company's silicon nitride expertise. Revenue recognition will follow U.S. GAAP upon performance obligation satisfaction.
4mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $109.29 | -1.06% | $1,89,283.94M | 36.28 | |
| $449.53 | -0.11% | $1,55,826.88M | 42.73 | |
| $101.61 | +0.02% | $1,29,976.46M | 24.46 | |
| $318.79 | -1.70% | $1,21,360.48M | 34.27 | |
| $45.13 | +0.96% | $65,414.72M | 18.96 | |
| $105.81 | +1.73% | $60,840.75M | 53.70 | |
| $214.52 | +0.90% | $58,432.46M | 44.07 | |
| $82.60 | -1.26% | $37,346.60M | 16.49 | |
| $42.16 | +3.06% | $37,044.18M | 89.05 | |
| $72.46 | -2.16% | $35,027.16M | 54.55 | |
| $237.20 | +1.61% | $33,458.08M | 23.04 | |
| $80.35 | +0.53% | $29,964.75M | 36.04 |
An investment of $100 made 5 years ago in SINTX Technologies is now worth
$ 0.01
Resulting in a loss of
$ 99.99 (99.99%)
Note: Past profits do not guarantee future returns.
